Description
This peptide is a derivative of the N-terminal end of cecropin B and the C-terminal end of thanatin that exhibits antimicrobial peptide (AMP) activity.
This peptide is a derivative of the N-terminal end of cecropin B and the C-terminal end of thanatin that exhibits antimicrobial peptide (AMP) activity.
| Purity | ≥95% |
|---|---|
| Formula | C138H230N46O34S4 |
| Formula Wt. | 3205.89 |
| Solubility | Soluble in water. |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet |
Hongbiao W, Baolong N, Mengkui X, et al. Biological activities of cecropin B-thanatin hybrid peptides. J Pept Res. 2005 Dec;66(6):382-6. PMID: 16316454.
Nucleoside (guanosine) analog; RT, guanylyl cyc...
M4 mAChR agonist, 5-HT1A partial agonist, M1/2/...
Impurity of diclofenac
NSAID; COX-1/2 and lipoxygenase inhibitor.
Purine derivative; CDK inhibitor.
Steroid lactone produced by Withania somnifera;...
Oligopeptide found in Actinomycetes; protease i...
β2-adrenergic agonist.
Synthetic peptide, retroviral envelope protein ...
Sulfonamide; dihydropteroate synthase inhibitor...
Oxazolidone derivative; Factor Xa inhibitor.
PDE3 inhibitor.
Synthetic vitamin E, antioxidant.
Steroid; glucocorticoid agonist.
Niacin derivative.
Indirect activator of STING signaling
Aminothiol, CoA component; ulcer inducer.
Glycylcycline; protein synthesis inhibitor.
MEK inhibitor.
ITC, erysolin analog.